Yael P Mosse

This study aimed to give children with relapsed or hard-to-treat neuroblastoma a personalized treatment plan. Doctors would analyze the tumor's genes and pick a combination of targeted drugs to attack the specific mutations found. The trial was stopped early, so results are limit…